{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:19:10Z","timestamp":1784099950722,"version":"3.55.0"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCR"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Iron deficiency anemia (IDA) is highly prevalent among individuals with heart failure\n(HF), impacting 40-70% of patients and serving as a significant prognostic indicator. Linked\nwith oxidative metabolism and myocardial cell damage, IDA exacerbates HF symptoms, including\nreduced exercise capacity, diminished quality of life, and heightened cardiovascular morbidity.\nThis review explores the diagnosis, treatment, clinical outcomes, prognostic indicators,\nand forthcoming challenges associated with IDA in HF patients. Crucially, addressing IDA in\nHF is critical for enhancing prognosis, including clinical outcomes, quality of life, hospitalizations,\nand survival rates. While oral iron therapy shows efficacy in reducing mortality and hospitalizations,\nit falls short in improving exercise capacity and quality of life, often deterring patients\ndue to side effects. In contrast, intravenous (IV) iron therapy is highly effective in enhancing\nhematological parameters, functional capacity, and reducing HF hospitalizations. Optimizing\nIV iron dosing based on individual patient characteristics is essential for balancing treatment efficacy\nand adverse effects. Emphasizing individualized approaches, with IV iron emerging as a\nsuperior option, underscores the necessity for ongoing research to refine dosing strategies and\nexplore novel therapies. Compliance remains paramount for positive outcomes with IDA treatment,\nwith oral supplementation being cost-effective and easily accessible. However, parenteral\nsupplementation proves beneficial for patients intolerant to oral therapy. Addressing IDA\nthrough tailored interventions, including oral or parenteral supplementation, is pivotal in averting\ncomplications and improving outcomes in HF patients. This paper consolidates insights into\nthe diagnosis, treatment, impact, pathophysiology, clinical outcomes, research gaps, and future\ndirections concerning IDA in HF patients, drawing on extensive literature to offer a comprehensive\nunderstanding of this critical issue.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/011573403x331380241111091452","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T23:35:31Z","timestamp":1736292931000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Intersection of Heart Failure and Iron Deficiency Anemia: Diagnostic and Therapeutic Approaches"],"prefix":"10.2174","volume":"21","author":[{"given":"Maleesha Bw","family":"Thammitage","sequence":"first","affiliation":[{"name":"Aloka Medical Center, Horona, Ratnapura, Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naji","family":"Moussa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Richmond Gabriel University,\nKingstown, St. Vincent, Caribbean"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rezvani","sequence":"additional","affiliation":[{"name":"School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damandeep Kaur","family":"Dhillon","sequence":"additional","affiliation":[{"name":"Saint James School of Medicine, Dallas, TX 75238, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miryam Lisseth Obando","family":"Gamarra","sequence":"additional","affiliation":[{"name":"Universidad Andina del Cusco, Cusco, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwaraj","family":"Singh","sequence":"additional","affiliation":[{"name":"Maharishi\nMarkendeshwar Institute of Medical Sciences and Research, Ambala, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Hawwa","sequence":"additional","affiliation":[{"name":"School of Medicine, St. George\u2019s\nUniversity, Grenada, West Indies"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra Felix","family":"Vicente","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Universidad de Sonora, Sonora, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehajpreet","family":"Kaur","sequence":"additional","affiliation":[{"name":"Punjab\nInstitute of Medical Sciences, Jalandhar, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiranmayee Seshasai","family":"Nemalapuri","sequence":"additional","affiliation":[{"name":"Massachusetts College of Pharmacy and Health Sciences,\nBoston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devika","family":"Poonwassie","sequence":"additional","affiliation":[{"name":"Department of Internel Medicine, University of West Indies, St. Augustine, Trinidad and\nTobago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Shri Venkateshwara University, Gajraula, Ludhiana, Uttar Pradesh,\nIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/ehf2.13265","volume":"8","author":"Loncar G.","year":"2021","unstructured":"Loncar G.; Obradovic D.; Thiele H.; von Haehling S.; Lainscak M.; Iron deficiency in heart failure. ESC Heart Fail  2021,8(4),2368-2379","journal-title":"ESC Heart Fail"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.3390\/jcm11112976","volume":"11","author":"Sindone A.","year":"2022","unstructured":"Sindone A.; Doehner W.; Manito N.; Practical guidance for diagnosing and treating iron deficiency in patients with heart failure: Why, Who and How? J Clin Med  2022,11(11),2976","journal-title":"J Clin Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/diagnostics13020304","volume":"13","author":"Singer C.E.","year":"2023","unstructured":"Singer C.E.; Vasile C.M.; Popescu M.; Role of iron deficiency in heart failure-clinical and treatment approach: An overview. Diagnostics (Basel)  2023,13(2),304","journal-title":"Diagnostics (Basel)"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/ehf2.12797","volume":"7","author":"Chopra V.K.","year":"2020","unstructured":"Chopra V.K.; Anker S.D.; Anaemia, iron deficiency and heart failure in 2020: Facts and numbers. ESC Heart Fail  2020,7(5),2007-2011","journal-title":"ESC Heart Fail"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/ijms21030725","volume":"21","author":"Gluba-Brz\u00f3zka A.","year":"2020","unstructured":"Gluba-Brz\u00f3zka A.; Franczyk B.; Olszewski R.; Rysz J.; The influence of inflammation on anemia in CKD patients. Int J Mol Sci  2020,21(3),725","journal-title":"Int J Mol Sci"},{"key":"ref=6","author":"Shaikh H.","year":"2024","unstructured":"Shaikh H.; Hashmi M.F.; Aeddula N.R.; Anemia of chronic kidney disease. In: StatPearls  2024","journal-title":"In: StatPearls"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"819329","DOI":"10.3389\/fonc.2021.819329","volume":"11","author":"Yang Z.","year":"2022","unstructured":"Yang Z.; Wang D.; Zhang C.; The applications of gold nanoparticles in the diagnosis and treatment of gastrointestinal cancer. Front Oncol  2022,11,819329","journal-title":"Front Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"a011866","DOI":"10.1101\/cshperspect.a011866","volume":"3","author":"Miller J.L.","year":"2013","unstructured":"Miller J.L.; Iron deficiency anemia: A common and curable disease. Cold Spring Harb Perspect Med  2013,3(7),a011866","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1015639","DOI":"10.3389\/fcvm.2022.1015639","volume":"9","author":"Shi M.","year":"2022","unstructured":"Shi M.; Dong Z.; Zhao K.; Novel insights into exhaustive exercise-induced myocardial injury: Focusing on mitochondrial quality control. Front Cardiovasc Med  2022,9,1015639","journal-title":"Front Cardiovasc Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.carpath.2011.11.007","volume":"21","author":"Kemp C.D.","year":"2012","unstructured":"Kemp C.D.; Conte J.V.; The pathophysiology of heart failure. Cardiovasc Pathol  2012,21(5),365-371","journal-title":"Cardiovasc Pathol"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/CMR.00054-09","volume":"23","author":"Hidron H.","year":"2010","unstructured":"Hidron H.; Vogenthaler N.; Santos-Preciado J.I.; Cardiac involvement with parasitic infections. Clin Microbiol Rev  2010,23(2),324-349","journal-title":"Clin Microbiol Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","volume":"34","author":"Jankowska E.A.","year":"2013","unstructured":"Jankowska E.A.; von Haehling S.; Anker S.D.; Macdougall I.C.; Ponikowski P.; Iron deficiency and heart failure: Diagnostic dilemmas and therapeutic perspectives. Eur Heart J  2013,34(11),816-829","journal-title":"Eur Heart J"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","volume":"1","author":"Cleland J.G.F.","year":"2016","unstructured":"Cleland J.G.F.; Zhang J.; Pellicori P.; Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiol  2016,1(5),539-547","journal-title":"JAMA Cardiol"},{"key":"ref=14","first-page":"340","volume":"33","author":"Hegde N.","year":"2006","unstructured":"Hegde N.; Rich M.W.; Gayomali C.; The cardiomyopathy of iron deficiency. Tex Heart Inst J  2006,33(3),340-344","journal-title":"Tex Heart Inst J"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","volume":"7","author":"von Haehling S.","year":"2019","unstructured":"von Haehling S.; Ebner N.; Evertz R.; Ponikowski P.; Anker S.D.; Iron deficiency in heart failure. JACC Heart Fail  2019,7(1),36-46","journal-title":"JACC Heart Fail"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"eabi4852","DOI":"10.1126\/sciadv.abi4852","volume":"7","author":"Furrer R.","year":"2021","unstructured":"Furrer R.; Remodeling of metabolism and inflammation by exercise ameliorates tumor-associated anemia. Sci Adv  2021,7(37),eabi4852","journal-title":"Sci Adv"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.3390\/jcm11133900","volume":"11","author":"Peters C.J.","year":"2022","unstructured":"Peters C.J.; Hanff T.C.; Genuardi M.V.; Safety and effectiveness of intravenous iron therapy in patients supported by durable left ventricular assist devices. J Clin Med  2022,11(13),3900","journal-title":"J Clin Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","volume":"79","author":"Masini G.","year":"2022","unstructured":"Masini G.; Graham F.J.; Pellicori P.; Criteria for iron deficiency in patients with heart failure. J Am Coll Cardiol  2022,79(4),341-351","journal-title":"J Am Coll Cardiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/ejhf.1305","volume":"20","author":"McDonagh T.","year":"2018","unstructured":"McDonagh T.; Damy T.; Doehner W.; Screening, diagnosis and treatment of iron deficiency in chronic heart failure: Putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail  2018,20(12),1664-1672","journal-title":"Eur J Heart Fail"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/jcm11010125","volume":"11","author":"Alnuwaysir R.","year":"2021","unstructured":"Alnuwaysir R.; Hoes M.; van Veldhuisen D.; van der Meer P.; Grote Beverborg N.; Iron deficiency in heart failure: Mechanisms and pathophysiology. J Clin Med  2021,11(1),125","journal-title":"J Clin Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/jpm11070639","volume":"11","author":"Kaluzna-Oleksy M.","year":"2021","unstructured":"Kaluzna-Oleksy M.; Sawczak F.; Kukfisz A.; Appetite and nutritional status as potential management targets in patients with heart failure with reduced ejection fraction-the relationship between echocardiographic and biochemical parameters and appetite. J Pers Med  2021,11(7),639","journal-title":"J Pers Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1002\/ehf2.13629","volume":"8","author":"Takada T.","year":"2021","unstructured":"Takada T.; Jujo K.; Inagaki K.; Nutritional status during hospitalization is associated with the long-term prognosis of patients with heart failure. ESC Heart Fail  2021,8(6),5372-5382","journal-title":"ESC Heart Fail"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1461S","DOI":"10.3945\/ajcn.2010.28674F","volume":"91","author":"Hurrell R.","year":"2010","unstructured":"Hurrell R.; Egli I.; Iron bioavailability and dietary reference values. Am J Clin Nutr  2010,91(5),1461S-1467S","journal-title":"Am J Clin Nutr"},{"key":"ref=24","author":"Moustarah F.","year":"2024","unstructured":"Moustarah F.; Daley S.F.; Dietary iron. In: StatPearls  2024","journal-title":"In: StatPearls"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s43042-022-00362-1","volume":"23","author":"Mohd Atan F.N.E.","year":"2022","unstructured":"Mohd Atan F.N.E.; Wan Mohd Saman W.A.; Kamsani Y.S.; Khalid Z.; Abdul Rahman A.; TMPRSS6 gene polymorphisms associated with iron deficiency anaemia among global population. Egypt J Med Hum Genet  2022,23(1),147","journal-title":"Egypt J Med Hum Genet"},{"key":"ref=26","unstructured":"Clinical Liver Disease Available from:  https:\/\/journals.lww.com\/cld\/fulltext\/2020\/11000\/acg_clinical_guideline__hereditary_hemochromatosis.1.aspx"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/HJH.0b013e3283434784","volume":"29","author":"Naito Y.","year":"2011","unstructured":"Naito Y.; Tsujino T.; Fujimori Y.; Impaired expression of duodenal iron transporters in Dahl salt-sensitive heart failure rats. J Hypertens  2011,29(4),741-748","journal-title":"J Hypertens"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","volume":"138","author":"Anand I.S.","year":"2018","unstructured":"Anand I.S.; Gupta P.; Anemia and iron deficiency in heart failure. Circulation  2018,138(1),80-98","journal-title":"Circulation"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.scib.2021.02.010","volume":"66","author":"Mu Q.","year":"2021","unstructured":"Mu Q.; Chen L.; Gao X.; The role of iron homeostasis in remodeling immune function and regulating inflammatory disease. Sci Bull (Beijing)  2021,66(17),1806-1816","journal-title":"Sci Bull (Beijing)"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/jcm8091382","volume":"8","author":"Douwes R.M.","year":"2019","unstructured":"Douwes R.M.; Chronic use of proton-pump inhibitors and iron status in renal transplant recipients. J Clin Med  2019,8(9),1382","journal-title":"J Clin Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000356193","volume":"40","author":"Jelkmann W.","year":"2013","unstructured":"Jelkmann W.; Physiology and pharmacology of erythropoietin. Transfus Med Hemother  2013,40(5),302-309","journal-title":"Transfus Med Hemother"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"103209","DOI":"10.1016\/j.ebiom.2021.103209","volume":"64","author":"Miyauchi K.","year":"2021","unstructured":"Miyauchi K.; Nakai T.; Saito S.; Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions. EBioMedicine  2021,64,103209","journal-title":"EBioMedicine"},{"key":"ref=33","author":"Goyal A.","year":"2024","unstructured":"Goyal A.; Cusick A.S.; Thielemier B.; ACE Inhibitors. In: StatPearls  2024","journal-title":"In: StatPearls"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/bs.vh.2017.02.001","volume":"105","author":"Kim Y.C.","year":"2017","unstructured":"Kim Y.C.; Mungunsukh O.; Day R.M.; Erythropoietin regulation by angiotensin II. Vitam Horm  2017,105,57-77","journal-title":"Vitam Horm"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e0129484","DOI":"10.1371\/journal.pone.0129484","volume":"10","author":"Kato H.","year":"2015","unstructured":"Kato H.; Ishida J.; Matsusaka T.; Erythropoiesis and blood pressure are regulated via AT1 receptor by distinctive pathways. PLoS One  2015,10(6),e0129484","journal-title":"PLoS One"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e022853","DOI":"10.1161\/JAHA.121.022853","volume":"11","author":"Zhang H.","year":"2022","unstructured":"Zhang H.; Jamieson K.L.; Grenier J.; Myocardial iron deficiency and mitochondrial dysfunction in advanced heart failure in humans. J Am Heart Assoc  2022,11(11),e022853","journal-title":"J Am Heart Assoc"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","volume":"71","author":"Rocha B.M.L.","year":"2018","unstructured":"Rocha B.M.L.; Cunha G.J.L.; Menezes Falc\u00e3o L.F.; The burden of iron deficiency in heart failure. J Am Coll Cardiol  2018,71(7),782-793","journal-title":"J Am Coll Cardiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3390\/cells10092198","volume":"10","author":"Dietz J.V.","year":"2021","unstructured":"Dietz J.V.; Fox J.L.; Khalimonchuk O.; Down the iron path: Mitochondrial iron homeostasis and beyond. Cells  2021,10(9),2198","journal-title":"Cells"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fcvm.2018.00068","volume":"5","author":"Karwi Q.G.","year":"2018","unstructured":"Karwi Q.G.; Uddin G.M.; Ho K.L.; Lopaschuk G.D.; Loss of metabolic flexibility in the failing heart. Front Cardiovasc Med  2018,5,68","journal-title":"Front Cardiovasc Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/CIA.S27105","volume":"8","author":"Agarwal A.","year":"2013","unstructured":"Agarwal A.; Shah. Anemia associated with chronic heart failure: current concepts. Clin Interv Aging  2013,8,111-122","journal-title":"Clin Interv Aging"},{"key":"ref=41","first-page":"241","volume":"11","author":"Jimenez K.","year":"2015","unstructured":"Jimenez K.; Kulnigg-Dabsch S.; Gasche C.; Management of iron deficiency anemia. Gastroenterol Hepatol (N Y)  2015,11(4),241-250","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"M32","DOI":"10.1093\/eurheartj\/suz231","volume":"21","author":"Jankowska E.A.","year":"2019","unstructured":"Jankowska E.A.; Tkaczyszyn M.; Drozd M.; Ponikowski P.; Monitoring of iron status in patients with heart failure. Eur Heart J Suppl  2019,21(Suppl. M),M32-M35","journal-title":"Eur Heart J Suppl"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"I96","DOI":"10.1093\/eurheartjsupp\/suac080","volume":"24","author":"Del Pinto R.","year":"2022","unstructured":"Del Pinto R.; Ferri C.; Iron deficiency in heart failure: Diagnosis and clinical implications. Eur Heart J Suppl  2022,24(Suppl. I),I96-I99","journal-title":"Eur Heart J Suppl"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3238\/arztebl.m2021.0290","volume":"118","author":"Gattermann N.","year":"2021","unstructured":"Gattermann N.; Muckenthaler M.U.; Kulozik A.E.; Metzgeroth G.; Hastka J.; The evaluation of iron deficiency and iron overload. Dtsch Arztebl Int  2021,118(49),847-856","journal-title":"Dtsch Arztebl Int"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bpa.2023.11.001","volume":"37","author":"Rusch J.A.","year":"2023","unstructured":"Rusch J.A.; van der Westhuizen D.J.; Gill R.S.; Louw V.J.; Diagnosing iron deficiency: Controversies and novel metrics. Baillieres Best Pract Res Clin Anaesthesiol  2023,37(4),451-467","journal-title":"Baillieres Best Pract Res Clin Anaesthesiol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.hoc.2014.04.005","volume":"28","author":"Nemeth E.","year":"2014","unstructured":"Nemeth E.; Ganz T.; Anemia of inflammation. Hematol Oncol Clin North Am  vi.2014,28(4),671-681","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e004519","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","volume":"11","author":"Grote Beverborg N.","year":"2018","unstructured":"Grote Beverborg N.; Klip I.J.T.; Meijers W.C.; Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients. Circ Heart Fail  2018,11(2),e004519","journal-title":"Circ Heart Fail"},{"key":"ref=48","first-page":"9394060","volume":"2018","author":"Dignass A.","year":"2018","unstructured":"Dignass A.; Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int J Chronic Dis  2018,2018,9394060","journal-title":"Int J Chronic Dis"},{"key":"ref=49","first-page":"682054","volume":"2015","author":"Mozos I.","year":"2015","unstructured":"Mozos I.; Mechanisms linking red blood cell disorders and cardiovascular diseases. Biomed Res Int  2015,2015,682054","journal-title":"Biomed Res Int"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40001-022-00922-6","volume":"28","author":"Rohr M.","year":"2023","unstructured":"Rohr M.; Brandenburg V.; Brunner-La Rocca H.P.; How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome. Eur J Med Res  2023,28(1),15","journal-title":"Eur J Med Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11886-023-01889-4","volume":"25","author":"Shamsi A.","year":"2023","unstructured":"Shamsi A.; Cannata A.; Piper S.; Bromage D.I.; McDonagh T.A.; Treatment of iron deficiency in heart failure. Curr Cardiol Rep  2023,25(7),649-661","journal-title":"Curr Cardiol Rep"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5334\/gh.1151","volume":"17","author":"Suryani L.D.","year":"2022","unstructured":"Suryani L.D.; Raharjo S.B.; Sagita R.; Oral ferrous sulphate improves functional capacity on heart failure patients with iron deficiency anemia. Glob Heart  2022,17(1),81","journal-title":"Glob Heart"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"106345","DOI":"10.1016\/j.phrs.2022.106345","volume":"182","author":"Mei Z.","year":"2022","unstructured":"Mei Z.; Chen J.; Luo S.; Jin L.; Liu Q.; Chen Y.; Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials. Pharmacol Res  2022,182,106345","journal-title":"Pharmacol Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"e48717","DOI":"10.7759\/cureus.48717","volume":"15","author":"Yun L.","year":"2023","unstructured":"Yun L.; YuMei Z, Bn V, Tang Q, Feng C. The efficacy, safety, and economic outcomes of using ferric derisomaltose for the management of iron deficiency in China: A rapid health technology assessment. Cureus  2023,15(11),e48717","journal-title":"Cureus"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/ph11030082","volume":"11","author":"Bhandari S.","year":"2018","unstructured":"Bhandari S.; Pereira D.I.A.; Chappell H.F.; Drakesmith H.; Intravenous irons: From basic science to clinical practice. Pharmaceuticals (Basel)  2018,11(3),82","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","volume":"389","author":"Mentz R.J.","year":"2023","unstructured":"Mentz R.J.; Garg J.; Rockhold F.W.; Ferric carboxymaltose in heart failure with iron deficiency. N Engl J Med  2023,389(11),975-986","journal-title":"N Engl J Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","volume":"396","author":"Ponikowski P.","year":"2020","unstructured":"Ponikowski P.; Kirwan B.A.; Anker S.D.; Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: A multicentre, double-blind, randomised, controlled trial. Lancet  2020,396(10266),1895-1904","journal-title":"Lancet"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","volume":"400","author":"Kalra P.R.","year":"2022","unstructured":"Kalra P.R.; Cleland J.G.F.; Petrie M.C.; Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): An investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet  2022,400(10369),2199-2209","journal-title":"Lancet"},{"key":"ref=59","year":"2024","unstructured":"Effect of IV iron in patients with heart failure with preserved ejection fraction (FAIR-HFpEF). NCT03074591  2024","journal-title":"NCT03074591"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2450\/2018.0156-18","volume":"17","author":"G\u00f3mez-Ram\u00edrez S.","year":"2019","unstructured":"G\u00f3mez-Ram\u00edrez S.; Shander A.; Spahn D.R.; Prevention and management of acute reactions to intravenous iron in surgical patients. Blood Transfus  2019,17(2),137-145","journal-title":"Blood Transfus"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","volume":"6","author":"Tangvarasittichai S.","year":"2015","unstructured":"Tangvarasittichai S.; Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes  2015,6(3),456-480","journal-title":"World J Diabetes"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40264-018-0769-5","volume":"42","author":"Ehlken B.","year":"2019","unstructured":"Ehlken B.; Nathell L.; Gohlke A.; Bocuk D.; Toussi M.; Wohlfeil S.; Evaluation of the reported rates of severe hypersensitivity reactions associated with ferric carboxymaltose and iron (III) isomaltoside 1000 in Europe based on data from eudravigilance and VigiBase\u2122 between 2014 and 2017. Drug Saf  2019,42(3),463-471","journal-title":"Drug Saf"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s11096-023-01548-2","volume":"45","author":"Kennedy N.A.","year":"2023","unstructured":"Kennedy N.A.; Achebe M.M.; Biggar P.; P\u00f6hlmann J.; Pollock R.F.; A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose. Int J Clin Pharm  2023,45(3),604-612","journal-title":"Int J Clin Pharm"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.122.060511","volume":"146","author":"Docherty K.F.","year":"2022","unstructured":"Docherty K.F.; Welsh P.; Verma S.; Iron deficiency in heart failure and effect of dapagliflozin: Findings from DAPA-HF. Circulation  2022,146(13),980-994","journal-title":"Circulation"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","year":"2022","unstructured":"2022 AHA\/ACC\/HFSA Guideline for the management of heart Failure: A report of the American college of cardiology\/American Heart Association Joint Committee on clinical practice guidelines. JACC  2022,79(17),e263-e421","journal-title":"JACC"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1080\/00015385.2019.1625554","volume":"75","author":"Martens P.","year":"2020","unstructured":"Martens P.; Minten L.; Dupont M.; Mullens W.; The importance of dose optimisation in the treatment of iron deficiency in heart failure. Acta Cardiol  2020,75(6),520-524","journal-title":"Acta Cardiol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jchf.2021.04.005","volume":"9","author":"Jhund P.S.","year":"2021","unstructured":"Jhund P.S.; Petrie M.C.; Robertson M.; Heart failure hospitalization in adults receiving hemodialysis and the effect of intravenous iron therapy. JACC Heart Fail  2021,9(7),518-527","journal-title":"JACC Heart Fail"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"100873","DOI":"10.1016\/j.mam.2020.100873","volume":"75","author":"Punj S.","year":"2020","unstructured":"Punj S.; Ghafourian K.; Ardehali H.; Iron deficiency and supplementation in heart failure and chronic kidney disease. Mol Aspects Med  2020,75,100873","journal-title":"Mol Aspects Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.2215\/CJN.0000000000000223","volume":"18","author":"Macdougall I.C.","year":"2023","unstructured":"Macdougall I.C.; Ponikowski P.; Stack A.G.; Ferric carboxymaltose in iron-deficient patients with hospitalized heart failure and reduced kidney function. Clin J Am Soc Nephrol  2023,18(9),1124-1134","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000493551","volume":"48","author":"Macdougall I.C.","year":"2018","unstructured":"Macdougall I.C.; White C.; Anker S.D.; Randomized trial comparing proactive, high-dose versus reactive, low-dose intravenous iron supplementation in hemodialysis (PIVOTAL): Study design and baseline data. Am J Nephrol  2018,48(4),260-268","journal-title":"Am J Nephrol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e000345","DOI":"10.1161\/CIRCHEARTFAILURE.115.000345","volume":"9","author":"Lewis G.D.","year":"2016","unstructured":"Lewis G.D.; Semigran M.J.; Givertz M.M.; Oral iron therapy for heart failure with reduced ejection fraction. Circ Heart Fail  2016,9(5),e000345","journal-title":"Circ Heart Fail"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","volume":"51","author":"Okonko D.O.","year":"2008","unstructured":"Okonko D.O.; Grzeslo A.; Witkowski T.; Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: A randomized, controlled, observer-blinded trial. J Am Coll Cardiol  2008,51(2),103-112","journal-title":"J Am Coll Cardiol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1016\/j.ijcard.2013.06.045","volume":"168","author":"Gutzwiller F.S.","year":"2013","unstructured":"Gutzwiller F.S.; Pfeil A.M.; Comin-Colet J.; Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis. Int J Cardiol  2013,168(4),3878-3883","journal-title":"Int J Cardiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/eurjhf\/hft099","volume":"15","author":"Filippatos G.","year":"2013","unstructured":"Filippatos G.; Farmakis D.; Colet J.C.; Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: A subanalysis of the FAIR-HF trial. Eur J Heart Fail  2013,15(11),1267-1276","journal-title":"Eur J Heart Fail"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/ejhf.2860","volume":"25","author":"Anker S.D.","year":"2023","unstructured":"Anker S.D.; Khan M.S.; Butler J.; Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta\u2010analysis. Eur J Heart Fail  2023,25(7),1080-1090","journal-title":"Eur J Heart Fail"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"e008100","DOI":"10.1161\/CIRCHEARTFAILURE.120.008100","volume":"14","author":"Mentz R.J.","year":"2021","unstructured":"Mentz R.J.; Ambrosy A.P.; Ezekowitz J.A.; Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: Rationale and design. Circ Heart Fail  2021,14(5),e008100","journal-title":"Circ Heart Fail"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"e41895","DOI":"10.7759\/cureus.41895","volume":"15","author":"Ogugua F.M.","year":"2023","unstructured":"Ogugua F.M.; Aguilar F.A.; Gamam A.; Treating iron deficiency (ID) anemia in heart failure (HF) patients with IV iron: A meta-analysis. Cureus  2023,15(7),e41895","journal-title":"Cureus"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ehf2.12485","volume":"6","author":"Jacob C.","year":"2019","unstructured":"Jacob C.; Altevers J.; Barck I.; Hardt T.; Braun S.; Greiner W.; Retrospective analysis into differences in heart failure patients with and without iron deficiency or anaemia. ESC Heart Fail  2019,6(4),840-855","journal-title":"ESC Heart Fail"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ejhf.1042","volume":"20","author":"Cheema B.","year":"2018","unstructured":"Cheema B.; Ambrosy A.P.; Kaplan R.M.; Lessons learned in acute heart failure. Eur J Heart Fail  2018,20(4),630-641","journal-title":"Eur J Heart Fail"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/life12111828","volume":"12","author":"L\u00f3pez-Vilella R.","year":"2022","unstructured":"L\u00f3pez-Vilella R.; Donoso Trenado V.; Jover Pastor P.; S\u00e1nchez-L\u00e1zaro I.; Mart\u00ednez Dolz L.; Almenar Bonet L.; Why iron deficiency in acute heart failure should be treated: A real-world clinical practice study. Life (Basel)  2022,12(11),1828","journal-title":"Life (Basel)"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"Ponikowski P.","year":"2015","unstructured":"Ponikowski P.; van Veldhuisen D.J.; Comin-Colet J.; Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J  2015,36(11),657-668","journal-title":"Eur Heart J"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ejhf.2092","volume":"23","author":"Karavidas A.","year":"2021","unstructured":"Karavidas A.; Troganis E.; Lazaros G.; Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open\u2010label, proof\u2010of\u2010concept study. Eur J Heart Fail  2021,23(4),593-597","journal-title":"Eur J Heart Fail"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/heartjnl-2014-305669","volume":"100","author":"Cohen-Solal A.","year":"2014","unstructured":"Cohen-Solal A.; Leclercq C.; Deray G.; Iron deficiency: An emerging therapeutic target in heart failure. Heart  2014,100(18),1414-1420","journal-title":"Heart"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3324\/haematol.2014.111492","volume":"99","author":"Rampton D.","year":"2014","unstructured":"Rampton D.; Folkersen J.; Fishbane S.; Hypersensitivity reactions to intravenous iron: Guidance for risk minimization and management. Haematologica  2014,99(11),1671-1676","journal-title":"Haematologica"},{"key":"ref=85","author":"Banerjee S.","year":"2019","unstructured":"Banerjee S.; McCormack S.; Intravenous iron preparations for patients undergoing elective surgery: A review of clinical effectiveness, cost-effectiveness, and guidelines. In: CADTH rapid response\treport: Summary with critical appraisal Ottawa (ON):  2019","journal-title":"In: CADTH rapid response\treport: Summary with critical appraisal Ottawa (ON):"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/ehf2.14255","volume":"10","author":"Behnoush A.H.","year":"2023","unstructured":"Behnoush A.H.; Khalaji A.; Naderi N.; Ashraf H.; von Haehling S.; ACC\/AHA\/HFSA 2022 and ESC 2021 guidelines on heart failure comparison. ESC Heart Fail  2023,10(3),1531-1544","journal-title":"ESC Heart Fail"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/ehf2.12333","volume":"5","author":"Lam C.S.P.","year":"2018","unstructured":"Lam C.S.P.; Doehner W.; Comin-Colet J.; Iron deficiency in chronic heart failure: Case\u2010based practical guidance. ESC Heart Fail  2018,5(5),764-771","journal-title":"ESC Heart Fail"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"Heidenreich P.A.","year":"2022","unstructured":"Heidenreich P.A.; Bozkurt B.; Aguilar D.; 2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation  2022,145(18),e895-e1032","journal-title":"Circulation"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/microbiolres12020033","volume":"12","author":"Bloor S.R.","year":"2021","unstructured":"Bloor S.R.; Schutte R.; Hobson A.R.; Oral iron supplementation-Gastrointestinal side effects and the impact on the gut microbiota. Microbiol Res (Pavia)  2021,12(2),491-502","journal-title":"Microbiol Res (Pavia)"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"20441","DOI":"10.1021\/acsomega.2c01833","volume":"7","author":"Piskin E.","year":"2022","unstructured":"Piskin E.; Cianciosi D.; Gulec S.; Tomas M.; Capanoglu E.; Iron absorption: Factors, limitations, and improvement methods. ACS Omega  2022,7(24),20441-20456","journal-title":"ACS Omega"},{"key":"ref=91","author":"Ems T.","year":"2024","unstructured":"Ems T.; St Lucia K.; Huecker M.R.; Biochemistry, iron absorption. In: StatPearls  2024","journal-title":"In: StatPearls"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"100215","DOI":"10.1016\/j.advnut.2024.100215","volume":"15","author":"Cohen C.T.","year":"2024","unstructured":"Cohen C.T.; Powers J.M.; Nutritional strategies for managing iron deficiency in adolescents: Approaches to a challenging but common problem. Adv Nutr  2024,15(5),100215","journal-title":"Adv Nutr"},{"key":"ref=93","author":"Nguyen M.","year":"2024","unstructured":"Nguyen M.; Tadi P.; Iron Supplementation. In: StatPearls  2024","journal-title":"In: StatPearls"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.3390\/nu14132724","volume":"14","author":"Skolmowska D.","year":"2022","unstructured":"Skolmowska D.; G\u0142\u0105bska D.; Ko\u0142ota A.; Guzek D.; Effectiveness of dietary interventions to treat iron-deficiency anemia in women: A systematic review of randomized controlled trials. Nutrients  2022,14(13),2724","journal-title":"Nutrients"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/ajh.24820","volume":"92","author":"Cappellini M.D.","year":"2017","unstructured":"Cappellini M.D.; Comin-Colet J.; de Francisco A.; Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol  2017,92(10),1068-1078","journal-title":"Am J Hematol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/joim.13503","volume":"292","author":"Cacoub P.","year":"2022","unstructured":"Cacoub P.; Choukroun G.; Cohen-Solal A.; Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action. J Intern Med  2022,292(4),542-556","journal-title":"J Intern Med"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"e65505","DOI":"10.7759\/cureus.65505","volume":"16","author":"Ghamri R.","year":"2024","unstructured":"Ghamri R.; Alsulami H.; Intravenous iron versus oral iron administration for the treatment of iron deficiency anemia: A patient-preference study. Cureus  2024,16(7),e65505","journal-title":"Cureus"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/07853890.2020.1867323","volume":"53","author":"Richards T.","year":"2021","unstructured":"Richards T.; Breymann C.; Brookes M.J.; Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice. Ann Med  2021,53(1),274-285","journal-title":"Ann Med"},{"key":"ref=99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.05.014","author":"Kido K","unstructured":"Kido K; Beavers CJ; Dulnuan K; Management of iron deficiency in heart failure. JACC Heart Fail  2024; S2213-1779(24): 00433-5.","journal-title":"JACC Heart Fail"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1182\/asheducation-2016.1.57","volume":"2016","author":"Auerbach M.","year":"2016","unstructured":"Auerbach M.; Deloughery T.; Single-dose intravenous iron for iron deficiency: A new paradigm. Hematology (Am Soc Hematol Educ Program)  2016,2016(1),57-66","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/imj.16184","volume":"54","author":"Lucas S.","year":"2024","unstructured":"Lucas S.; Garg M.; Intravenous iron: An update. Intern Med J  2024,54(1),26-34","journal-title":"Intern Med J"}],"container-title":["Current Cardiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/011573403X331380241111091452","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/238013\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/011573403X331380241111091452","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T06:26:43Z","timestamp":1758695203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/238013\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/011573403x331380241111091452","relation":{},"ISSN":["1573-403X"],"issn-type":[{"value":"1573-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e1573403X331380"}}